Well Told Grants

Federal grant programs / Drug Use and Addiction Research Programs

Drug Use and Addiction Research Programs in Utah

Drug Use and Addiction Research Programs (93.279) awarded $58.2 million to recipients in Utah in 37 grants from fiscal 2021 to 2025, 0.8% of the program's national total. University of Utah received the most, $51.0 million.

By year

Grants under this program to recipients in Utah
Fiscal yearAwardsAmount
FY 202115$12.1 million
FY 202215$9.9 million
FY 202312$12.7 million
FY 202420$13.1 million
FY 202515$10.4 million

Recipients in Utah

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
University of UtahColleges and universities25$51.0 million
Axcend LLCSmall businesses1$1.9 million
Brigham Young UniversityColleges and universities2$1.7 million
Strengthening Families Program LLCSmall businesses1$1.1 million
Utah State UniversityColleges and universities4$1.1 million
Photopharmics, Inc.Small businesses2$639,254
Ncap Medical, LLCSmall businesses1$416,443
Rebel Medicine IncSmall businesses1$295,921

Counted by the recipient's location. A recipient based in Utah may carry out the work elsewhere.

Open opportunities under this program

See all 109 on the program page

Questions people ask

How much Drug Use and Addiction Research Programs money goes to Utah?

$58.2 million from fiscal 2021 to 2025, across 37 awards. Utah ranks 27th of 50 states and territories for this program.

Who receives Drug Use and Addiction Research Programs money in Utah?

The largest recipient is University of Utah, with $51.0 million in 25 awards. Next are Axcend LLC and Brigham Young University.

Can organizations in Utah apply now?

Yes, 109 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Drug Use and Addiction Research Programs in other states

Other large programs in Utah

All federal grants in Utah

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.